In the BioHarmony Drug Report Database

"Preview" Icon

Adefovir dipivoxil

Hepsera (adefovir dipivoxil) is a small molecule pharmaceutical. Adefovir dipivoxil was first approved as Hepsera on 2002-09-20. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b.

 

Trade Name

 

Hepsera
 

Common Name

 

adefovir dipivoxil
 

ChEMBL ID

 

CHEMBL922
 

Indication

 

chronic hepatitis b, hepatitis b
 

Drug Class

 

Antivirals

Image (chem structure or protein)

Adefovir dipivoxil structure rendering